A high‐throughput screen for hyaluronic acid accumulation in recombinant Escherichia coli transformed by libraries of engineered sigma factors

Hyaluronic acid (HA) is an important biomaterial with functional medical and cosmetic applications. As its synthesis has been recently reported in recombinant bacteria, it is of interest to develop a high throughput screening method for the rapid isolation of HA accumulating strains transformed by combinatorial libraries. Here we report a novel two‐step screening strategy to select for better HA‐producing recombinant Escherichia coli strains transformed by mutation libraries of rpoD and rpoS, coding for the σD and σS factors of the RNA polymerase, respectively. The first screen, based on translucent colony morphology identification, was used to qualitatively distinguish HA‐producing strains on agar plates from non‐HA producing strains that exhibit dense colony morphology. The second screen was based on the photometric measurement of an alcian blue staining solution that precipitates with HA, creating an inverse relationship between HA concentration and alcian blue absorbance. The color attenuation fitted a second‐order polynomial between HA concentration and OD540 absorbance. Using the alcian blue absorbance quantification, 74 translucent colonies from the HA‐rpoD library and 78 translucent colonies from the HA‐rpoS library were isolated and cultured for optimal strain selection. Three representative superior recombinants with high, medium and low increase of HA accumulation, respectively, were identified by the screen from the HA‐rpoD and HA‐rpoS mutant library. Further flask culture confirmed that results of the library screen were reliable and the superior recombinant D72 highly accumulated HA of 561.4 mg/L with a productivity of ∼265 mg HA/g dry cell. Sequencing results showed that the mutant rpoD gene in D72 is in a truncated protein that lacks the conserved regions 3 and 4 of the σD. Generally, this two‐step high throughput screen presents a promising strategy for selecting superior HA‐producing strains from large scale mutation libraries. Biotechnol. Bioeng. 2008;101: 788–796. © 2008 Wiley Periodicals, Inc.

[1]  Rutherford Aris,et al.  The growth of competing microbial populations in a CSTR with periodically varying inputs , 1979 .

[2]  G. Stephanopoulos,et al.  Global transcription machinery engineering: a new approach for improving cellular phenotype. , 2007, Metabolic engineering.

[3]  D. Hoover,et al.  DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. , 2002, Nucleic acids research.

[4]  S. Lee,et al.  High cell density culture of metabolically engineered Escherichia coli for the production of poly(3-hydroxybutyrate) in a defined medium. , 1998, Biotechnology and bioengineering.

[5]  G. Stephanopoulos,et al.  Flux amplification in complex metabolic networks , 1997 .

[6]  G Stephanopoulos,et al.  Metabolic flux analysis of hybridoma continuous culture steady state multiplicity. , 1999, Biotechnology and bioengineering.

[7]  E. Balazs,et al.  The chemistry, biology and medical applications of hyaluronan and its derivatives , 1998 .

[8]  G. Stephanopoulos,et al.  Engineering Yeast Transcription Machinery for Improved Ethanol Tolerance and Production , 2006, Science.

[9]  T. Nyström,et al.  Negative regulation by RpoS: a case of sigma factor competition , 1998, Molecular microbiology.

[10]  M. Chamberlin,et al.  Structure and function of bacterial sigma factors. , 1988, Annual review of biochemistry.

[11]  J. Powers,et al.  Analysis and testing of biological stains-- The Biological Stain Commission Procedures , 2002, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[12]  P. Weigel,et al.  Molecular Cloning, Expression, and Characterization of the Authentic Hyaluronan Synthase from Group C Streptococcus equisimilis * , 1997, The Journal of Biological Chemistry.

[13]  I. Kakizaki,et al.  Inhibition of hyaluronan synthesis in Streptococcus equi FM100 by 4-methylumbelliferone. , 2002, European journal of biochemistry.

[14]  G. Stephanopoulos,et al.  Improvement of Xylose Uptake and Ethanol Production in Recombinant Saccharomyces cerevisiae through an Inverse Metabolic Engineering Approach , 2005, Applied and Environmental Microbiology.

[15]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[16]  Gregory Stephanopoulos,et al.  Carbon Flux Distributions at the Glucose 6‐Phosphate Branch Point in Corynebacterium glutamicum during Lysine Overproduction , 1994 .

[17]  K. Goa,et al.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. , 1994, Drugs.

[18]  V. Venturi.  Control of rpoS transcription in Escherichia coli and Pseudomonas: why so different? , 2003, Molecular microbiology.

[19]  G. Stephanopoulos,et al.  Multi-dimensional gene target search for improving lycopene biosynthesis in Escherichia coli. , 2007, Metabolic engineering.

[20]  G. Stephanopoulos,et al.  How to Make a Superior Cell , 2001, Science.

[21]  D. Oh,et al.  Selection of a Streptococcus equi mutant and optimization of culture conditions for the production of high molecular weight hyaluronic acid , 1996 .

[22]  K. Geider,et al.  Visualization of capsule formation by Erwinia amylovora and assays to determine amylovoran synthesis. , 1994, International journal of biological macromolecules.

[23]  P. Weigel,et al.  Hyaluronic Acid Production in Bacillus subtilis , 2005, Applied and Environmental Microbiology.

[24]  G. Stephanopoulos,et al.  Metabolic engineering of Escherichia coli for biosynthesis of hyaluronic acid. , 2008, Metabolic engineering.

[25]  G Stephanopoulos,et al.  Studies on on‐line bioreactor identification. IV. Utilization of pH measurements for product estimation , 1984, Biotechnology and bioengineering.

[26]  N. Diferrante.  Turbidimetric measurement of acid mucopolysaccharides and hyaluronidase activity. , 1956 .

[27]  A J Sinskey,et al.  Metabolic engineering--methodologies and future prospects. , 1993, Trends in biotechnology.

[28]  P. Weigel,et al.  Isolation of a Streptococcus pyogenes gene locus that directs hyaluronan biosynthesis in acapsular mutants and in heterologous bacteria. , 1993, The Journal of biological chemistry.

[29]  Gregory Stephanopoulos,et al.  Metabolic Activity Control of the L‐Lysine Fermentation by Restrained Growth Fed‐Batch Strategies , 1991 .

[30]  M. Wösten.  Eubacterial sigma-factors. , 1998, FEMS microbiology reviews.

[31]  F. Neidhardt,et al.  Culture Medium for Enterobacteria , 1974, Journal of bacteriology.

[32]  L. Nielsen,et al.  Amplifying the cellular reduction potential of Streptococcus zooepidemicus. , 2003, Journal of biotechnology.

[33]  G Stephanopoulos,et al.  Studies on on‐line bioreactor identification. I. Theory , 1984, Biotechnology and bioengineering.

[34]  Gregory Stephanopoulos,et al.  Carbon Flux Distributions at the Pyruvate Branch Point in Corynebacterium glutamicum during Lysine Overproduction , 1994 .

[35]  M. Gribskov,et al.  The sigma 70 family: sequence conservation and evolutionary relationships , 1992, Journal of bacteriology.

[36]  B. Gregory,et al.  An altered‐specificity DNA‐binding mutant of Escherichia coliσ70 facilitates the analysis of σ70 function in vivo , 2005 .